SEPTEMBER 2023LIFE SCIENCES REVIEW4CONTENTSCOVER STORY 12Featured CompanyTOP 10SOLUTIONS PROVIDERS - 2023CANCERIMMUNOTHERAPYTHE CANCER IMMUNOTHERAPY TREATMENT PARADIGMCharles G. Drake,M.D., Ph.D., Vice President,Immuno-Oncology, The Janssen Pharmaceutical Companies of Johnson & JohnsonOncotelicDr. Anthony E. Maida, III, Ph.D., MA, MBA, BA, BA CCO-Translational Medicine16
< Page 3 | Page 5 >